APLIF - Appili Therapeutics GAAP EPS of -C$0.05 revenue of C$1.4M February, 14 2022 05:45 PM Appili Therapeutics Inc Appili Therapeutics press release (OTCQX:APLIF): FQ3 GAAP EPS of -C$0.05. Revenue of C$1.4M (+4566.7% Y/Y). For further details see: Appili Therapeutics GAAP EPS of -C$0.05, revenue of C$1.4M